Drugmakers Urge FDA to Add PBPK Modeling to Food Effects Guidance

Drug Industry Daily
A A
Leading drugmakers are calling on the FDA to include the use of physiologically-based pharmacokinetic (PBPK) modeling in its draft guidance on assessing the effects of food on drugs in INDs and NDAs.

To View This Article:

Login

Subscribe To Drug Industry Daily